The aging population of the United States creates pharmaceutical challenges for the practicing emergency physician. Polypharmacy, drug-drug and drug-disease interactions, and other pharmaceutical complications from the pathophysiologic changes associated with aging need to be recognized in order to optimize outcomes in the elderly. Effective strategies that improve patients outcomes include a better understanding of the physiologic and pharmacologic changes that occur with aging, integrated use of clinical emergency department pharmacists, and choosing nonpharmacologic treatment options when possible.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2afml5Q
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Medical device regulation in India: What dermatologists need to know Sandeep Lahiry, Rajasree Sinha, Suparna Chatterjee Indian Journal of De...
-
Annals of Emergency Medicine from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2netsV5
-
"Who, are you!" "I am the Ghost of Christmas Present. And you are a weird little man!" He was small, but looked tall, ...
-
AP from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2nNxxOZ
-
Download this podcast on iTunes , SoundCloud or via RSS feed In this Inside EMS Podcast episode, co-hosts Chris Cebollero and Kelly Gra...
-
Abstract Indolent B cell lymphomas are a group of lymphoid malignancies characterized by their potential to undergo histologic transformat...
-
I recently had the honor and privilege of addressing a number of paramedic school commencement exercises. While it is always a privilege to ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου